HCMT
ALXA

Highland Capital Management (Tennessee)’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-340
Closed – – 642
2015
Q3 		$0 Hold
340
– – ﹤0.01% 707
2015
Q2 		$0 Buy
+340
New +$510 ﹤0.01% 677

Other funds holding ALXA

LPA
Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return

Highland Capital Management (Tennessee)'s ALXA Position: Q4 2015 in Review

Highland Capital Management (Tennessee) sold out of Alexza Pharmaceuticals Inc (ALXA) in Q4 2015, closing a stake of 340 shares.

Highland Capital Management (Tennessee) first reported a position in ALXA in Q2 2015 and held it in 2 quarters. The position peaked at $0 in Q3 2015. 26 funds tracked by Wall St. Rank hold ALXA as of Q4 2015.

  • Highland Capital Management (Tennessee) reported no remaining Alexza Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 340 Alexza Pharmaceuticals Inc shares in Q4 2015.
  • Highland Capital Management (Tennessee) first reported a position in Alexza Pharmaceuticals Inc in Q2 2015 and held it in 2 quarters.
  • Highland Capital Management (Tennessee)'s Alexza Pharmaceuticals Inc position peaked at $0 in Q3 2015.
  • 26 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q4 2015.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q4 2015, filed 27 Jan 2016.